Accordingly, DP DLBCL was enriched for SMAD1 methylation, providing a mechanism for DLBCL to overcome the potential anti-lymphoma role of TGFB mediated secreted by surrounding stroma [121]. The gene discussed is SMAD1; the disease is lymphoma.